NSA Controversy Bad for US Tech Companies

Most Americans are now worried about their privacy after the disclosure of the secret National Security Agency surveillance programs. In an effort to relieve the concerns, a senior administration official said that President Barack Obama’s Privacy and Civil Liberties Oversight Board is now reviewing the nation’s counterterrorism actions to guarantee that the actions is balanced with the need to protect civil liberties. Companies

US tech companies are now concerned that their businesses are at risk after the disclosures that they have been cooperating with the government’s data collection programs. They have been compelled by the US government with a court order to do stuff that is not in the best interests of their shareholders and customers.

Customers across the globe now know that the companies are sending data to the government. Some of the information is personal and this could affect the companies’ reputations. This could result to the downfall of American technology companies.

The profits of tech companies such as Facebook and Google could be affected by the NSA controversy. The companies are good sources for security and intelligence agencies. The companies collect personal data that are pulled into the surveillance business.

The US government is not the only intrusive one in the world. According to a report by Hogan Lovelis, a law firm specializing in privacy issues, US law imposes as much oversight on surveillance as laws in most European countries. But the reputations of the US tech companies have already suffered irreparable damage.

The reaction to the disclosures of the NSA programs in the United States would reverberate across the world, especially with regards to the monitoring of online communications. Most of internet activity is made through America or via American businesses. The controversy involving the NSA and US tech companies will have more costs in the US.



Latest News

Spring Bank Pharmaceuticals Inc  Short Interest Update
Spring Bank Pharmaceuticals Inc Short Interest Update
D. R. Horton  Hits New 12-Month High at $55.84
D. R. Horton Hits New 12-Month High at $55.84
Short Interest in aTyr Pharma Inc  Decreases By 48.1%
Short Interest in aTyr Pharma Inc Decreases By 48.1%
Aquestive Therapeutics  Shares Gap Down to $6.70
Aquestive Therapeutics Shares Gap Down to $6.70
Nasdacoin Price Tops $0.0369 on Top Exchanges
Nasdacoin Price Tops $0.0369 on Top Exchanges
ChainX Market Capitalization Hits $4.72 Million
ChainX Market Capitalization Hits $4.72 Million


 
© 2006-2019 Zolmax.